Iovance Biotherapeutics I... (IOVA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
6.20
-0.05 (-0.80%)
At close: Jan 28, 2025, 2:08 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
PE Ratio | -4.31 | -2.61 | -8.93 | -24.95 | -18.4 | -6.97 | -5.67 | -7.26 | -12.39 | -16.34 | -4.04 | -5.31 | -2.95 | -50.72 | -2.66K | -2.34K |
PS Ratio | 1.61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.27 | 2.04 | 4.71 | 9.77 | 11.51 | 1.85 | 3.59 | 2.30 | 3.30 | 4.38 | 5.82 | -1.55 | -5.94 | 127.82 | -3.11K | 58.49K |
P/FCF Ratio | -4.98 | -3.25 | -11.03 | -25.47 | -20.76 | -8.4 | -6.55 | -11.23 | -17.56 | -19.23 | -27.89 | -7.84 | -12.21 | -131.37 | -2.90K | -2.33K |
P/OCF Ratio | -5.28 | -3.48 | -12.85 | -31.28 | -21.66 | -8.5 | -6.63 | -11.76 | -18.65 | -22.78 | -27.99 | -7.84 | -12.27 | -131.37 | -2.90K | -2.33K |
OCF/S Ratio | -304.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.13 | 0.17 | 0.12 | 0.08 | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | -0.57 | -0.39 | n/a | n/a | n/a |
Quick Ratio | 2.70 | 5.16 | 5.69 | 11.59 | 8.00 | 33.02 | 15.09 | 34.12 | 63.79 | 27.06 | 8.74 | 0.00 | 0.04 | 1.58 | 0.36 | 0.92 |
Current Ratio | 2.79 | 5.16 | 5.69 | 11.59 | 8.00 | 33.02 | 15.09 | 34.12 | 63.79 | 27.06 | 8.74 | 0.00 | 0.04 | 1.58 | 0.36 | 0.92 |
Asset Turnover | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -133.63 | n/a | n/a | n/a | n/a | n/a | n/a | -139.3 | -2.13K | -50.91 | -3.36 | -140.05 | n/a | n/a | n/a |
Return on Equity (ROE) | -0.76 | -0.78 | -0.53 | -0.39 | -0.63 | -0.27 | -0.63 | -0.32 | -0.27 | -0.27 | -1.44 | 0.29 | 2.01 | -2.52 | 1.17 | -25.02 |
Return on Assets (ROA) | -0.57 | -0.59 | -0.42 | -0.33 | -0.54 | -0.26 | -0.59 | -0.31 | -0.26 | -0.26 | -1.28 | -112.45 | -45.2 | -1.1 | -1.64 | -10.18 |
Return on Capital (ROIC) | -0.69 | -0.7 | -0.5 | -0.37 | -0.68 | -0.27 | -0.64 | -0.32 | -0.27 | -0.27 | -1.29 | 0.72 | 1.66 | -1.28 | 1.17 | -25.02 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -804.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -37.35K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -37.64K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -38.73K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -32.31K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -35.95K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |